IRIS
Mazzola, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.713
AS - Asia 1.456
EU - Europa 809
SA - Sud America 395
Continente sconosciuto - Info sul continente non disponibili 76
AF - Africa 32
OC - Oceania 2
Totale 6.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.633
SG - Singapore 815
DE - Germania 468
BR - Brasile 319
CN - Cina 216
VN - Vietnam 191
IT - Italia 149
HK - Hong Kong 96
GB - Regno Unito 39
FR - Francia 37
IN - India 29
MX - Messico 27
AR - Argentina 26
CA - Canada 25
BD - Bangladesh 20
FI - Finlandia 16
EC - Ecuador 15
IQ - Iraq 15
AT - Austria 14
RU - Federazione Russa 13
ID - Indonesia 11
NL - Olanda 11
ZA - Sudafrica 11
IE - Irlanda 10
UZ - Uzbekistan 10
NG - Nigeria 9
UA - Ucraina 9
CO - Colombia 8
PK - Pakistan 7
PL - Polonia 7
SE - Svezia 7
VE - Venezuela 7
CR - Costa Rica 6
PE - Perù 6
PY - Paraguay 6
CL - Cile 5
ES - Italia 5
GT - Guatemala 5
MA - Marocco 5
TR - Turchia 5
AL - Albania 4
BB - Barbados 4
JM - Giamaica 4
LB - Libano 4
NP - Nepal 4
BG - Bulgaria 3
HN - Honduras 3
JP - Giappone 3
KH - Cambogia 3
LT - Lituania 3
MY - Malesia 3
OM - Oman 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
KE - Kenya 2
KR - Corea 2
MT - Malta 2
NI - Nicaragua 2
PT - Portogallo 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MN - Mongolia 1
PA - Panama 1
RO - Romania 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.409
Salva come PNG Salva come JPEG
Città #
Dallas 1.869
Falkenstein 420
Singapore 330
San Jose 218
Ashburn 187
The Dalles 127
Hong Kong 93
Council Bluffs 77
Beijing 70
Wilmington 63
Ho Chi Minh City 61
Chandler 55
Santa Clara 54
Hanoi 47
Milan 44
New York 44
Shanghai 43
Los Angeles 41
Phoenix 31
Rome 31
São Paulo 25
Ann Arbor 23
San Mateo 22
Naples 19
Orem 19
Princeton 18
Helsinki 16
Mexico City 15
Atlanta 11
Belo Horizonte 11
Brooklyn 11
Buffalo 11
Fairfield 11
Lawrence 11
Leawood 11
London 11
Boardman 10
Chicago 10
Da Nang 10
Denver 10
Dublin 10
Frankfurt am Main 10
Benin City 9
Düsseldorf 9
Newark 9
Tashkent 9
Chennai 8
Nuremberg 8
Amsterdam 7
Cleveland 7
Johannesburg 7
Miami 7
Montreal 7
Rio de Janeiro 7
Salvador 7
Woodbridge 7
Baghdad 6
Charlotte 6
Florence 6
Houston 6
Montes Claros 6
Portsmouth 6
Stamford 6
Boston 5
Bradenton 5
Curitiba 5
Fortaleza 5
Guarulhos 5
Guayaquil 5
Haiphong 5
Hillsboro 5
Lahore 5
Porto Alegre 5
San Francisco 5
Turin 5
Warsaw 5
Austin 4
Bridgetown 4
Can Tho 4
Cologno Monzese 4
Dhaka 4
Goiânia 4
Guatemala City 4
Joinville 4
Marília 4
Memphis 4
Paris 4
Quito 4
Saint Paul 4
San José 4
Seattle 4
Secaucus 4
Vienna 4
Asunción 3
Beirut 3
Erbil 3
Figino 3
Jundiaí 3
Kenosha 3
Kingston 3
Totale 4.514
Salva come PNG Salva come JPEG
Nome #
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients 691
1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes 635
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer 635
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment 605
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy 212
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 112
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 111
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 100
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 96
Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy? 92
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease 91
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 91
Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes 90
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 89
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 85
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer. 75
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 73
METASTASES-DIRECTED STEREOTACTIC RADIOTHERAPY FOR OLIGOMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER: MULTICENTRE SERIES OF 86 PATIENTS/117 LESIONS 72
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy 70
Stereotactic Body Radiation Therapy for thoracic nodes metastases, a multi-institutional experience 64
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time 63
Stereotactic radiosurgery for intracranial metastases: linac-based and gamma-dedicated unit approach. 63
Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy 62
Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system 60
Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity 60
Dose prescription in SBRT for early-stage non-small cell lung cancer: are we all speaking the same language? 56
Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer 56
SBRT FOR LYMPH NODE METASTASES FROM PROSTATE CANCER: A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS 56
SBRT for lymph node metastases from prostate cancer: a multi-institutional retrospective analysis 56
Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels®: Toxicity and Efficacy Analysis on a Retrospective Series of 305 Patients 55
Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 55
A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations 54
Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes 54
Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patients 54
The role of radiotherapy in patients with solid tumours after solid organ transplantation: a systematic review 53
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 53
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 52
Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy 52
Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac 51
Stereotactic Body Radiotherapy for a Rare Case of Sinonasal Metastasis Arising from Renal Cell Cancer 49
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 48
The Real Value of Stereotactic Ablative Radiotherapy (SABR) in Oligometastases: A Journey Into the Literature Evidence 48
Linac-based versus MR-guided SBRT for localized prostate cancer: a comparative evaluation of acute tolerability 48
Stereotactic Ablative radiation therapy (SABR) for cardiac arrhythmia: A new therapeutic option? 48
What is the role of reirradiation in the management of locoregionally relapsed non small-cell lung cancer? 47
Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes 47
Stereotactic radiotherapy for oligometastases in the lymph nodes 46
MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer 46
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases 45
PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer 45
Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology) 44
Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques? 43
A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study 43
Prognostic value of two geriatric screening tools in a cohort of older patients with early stage Non-Small Cell Lung Cancer treated with hypofractionated stereotactic radiotherapy 42
Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer 41
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 41
Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy 40
In reply to Simcock et al 39
SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity 39
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 39
Prostate re-irradiation: current concerns and future perspectives 38
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 38
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases 38
Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging 38
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness 37
The predictive and prognostic role of metabolic and volume-based parameters of positron emission tomography/computed tomography as non-invasive dynamic biological markers in early breast cancer treated with preoperative systemic therapy 35
Long-term disease outcome and volume-based decision strategy in a large cohort of multiple brain metastases treated with a mono-isocentric linac-based Stereotactic Radiosurgery technique 34
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 34
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal’s letter to the editor 32
Reirradiation on spine metastases: an Italian survey on behalf of palliative care and reirradiation study groups of Italian association of radiotherapy and clinical oncology (AIRO) 31
The use of SBRT in the management of oligometastatic gynecological cancer: report of promising results in terms of tolerability and clinical outcomes 27
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START) 14
Head-to-Head comparison of [18F]FES and [18F]FDG PET/CT in breast cancer patients: has a new era come? 5
Totale 6.483
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202248 0 0 0 14 0 1 0 9 3 5 14 2
2022/2023150 23 5 16 18 13 13 0 11 25 14 10 2
2023/202457 3 5 16 1 1 11 2 1 2 1 5 9
2024/2025842 2 13 11 3 2 101 144 64 83 201 94 124
2025/20264.463 237 359 1.613 333 94 124 456 607 143 186 156 155
2026/2027809 254 177 335 43 0 0 0 0 0 0 0 0
Totale 6.483